Semler Scientific, Inc.
SMLRNASDAQHealthcare
$20.33
$-1.04(-4.87%)
Market Cap$310745920
P/E Ratio—
52W High$65.98
52W Low$14.885
Semler Scientific, Inc. (SMLR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SMLR · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 17, 2026EPS Actual
$3.41
Est. -$0.54 · +731.5%
Revenue
—
Est. $0.00B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 17, 2026
After Market Close
▲ Beat EPS🔥 6-Quarter EPS Beat Streak
SMLR reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.37
Rev. $0.36B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.37
Rev. Est.$0.36B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Feb 17, 2026 | -$0.54 | $3.41 | +731.5% | — | $0.00B | — |
| ▲ Q4 FY2025 | Nov 12, 2025 | $0.04 | $1.07 | +2575.0% | $0.01B | $0.01B | -9.6% |
| ▲ Q3 FY2025 | Aug 4, 2025 | -$0.10 | $5.04 | +5140.0% | $0.01B | $0.01B | +2.8% |
| — Q2 FY2025 | May 13, 2025 | — | -$0.76 | — | $0.01B | — | — |
| ▲ Q1 FY2025 | Feb 18, 2025 | $0.26 | $3.41 | +1211.5% | $0.01B | $0.01B | +3.4% |
| ▲ Q4 FY2024 | Nov 4, 2024 | $0.37 | $0.72 | +94.6% | $0.01B | $0.01B | +12.6% |
| ▲ Q3 FY2024 | Aug 5, 2024 | $0.56 | $0.64 | +14.3% | $0.01B | $0.01B | +10.4% |
| ▼ Q2 FY2024 | May 7, 2024 | $1.03 | $0.78 | -24.3% | $0.02B | $0.02B | -25.7% |
Q1 FY2026
Feb 17, 2026Beat
EPS Actual
$3.41
EPS Est.
-$0.54
EPS Surpr.
+731.5%
Revenue
—
Q4 FY2025
Nov 12, 2025Beat
EPS Actual
$1.07
EPS Est.
$0.04
EPS Surpr.
+2575.0%
Revenue
$0.01B
Q3 FY2025
Aug 4, 2025Beat
EPS Actual
$5.04
EPS Est.
-$0.10
EPS Surpr.
+5140.0%
Revenue
$0.01B
Q2 FY2025
May 13, 2025
EPS Actual
-$0.76
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2025
Feb 18, 2025Beat
EPS Actual
$3.41
EPS Est.
$0.26
EPS Surpr.
+1211.5%
Revenue
$0.01B
Q4 FY2024
Nov 4, 2024Beat
EPS Actual
$0.72
EPS Est.
$0.37
EPS Surpr.
+94.6%
Revenue
$0.01B
Q3 FY2024
Aug 5, 2024Beat
EPS Actual
$0.64
EPS Est.
$0.56
EPS Surpr.
+14.3%
Revenue
$0.01B
Q2 FY2024
May 7, 2024Miss
EPS Actual
$0.78
EPS Est.
$1.03
EPS Surpr.
-24.3%
Revenue
$0.02B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.49 | $-0.49 | $-0.49 | 1 |
| Q3 FY2026 | $-0.47 | $-0.47 | $-0.47 | 1 |
| Q2 FY2026 | $-0.47 | $-0.47 | $-0.47 | 1 |
| Q1 FY2026 | $-0.49 | $-0.49 | $-0.49 | 1 |
| Q4 FY2025 | $-0.54 | $-0.54 | $-0.54 | 1 |
| Q3 FY2025 | $-0.34 | $-0.14 | $0.05 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Feb 17, 2026 | +731.5% | $20.33 | — | — |
| ▲ Q4 FY2025 | Nov 12, 2025 | +2575.0% | $27.35 | $25.73 | -5.92% |
| ▲ Q3 FY2025 | Aug 4, 2025 | +5140.0% | $34.46 | $35.37 | +2.64% |
| — Q2 FY2025 | May 13, 2025 | — | $34.84 | $36.70 | +5.34% |
| ▲ Q1 FY2025 | Feb 18, 2025 | +1211.5% | $49.67 | $50.72 | +2.11% |
| ▲ Q4 FY2024 | Nov 4, 2024 | +94.6% | $30.68 | $29.97 | -2.31% |
| ▲ Q3 FY2024 | Aug 5, 2024 | +14.3% | $29.10 | $26.32 | -9.55% |
| ▼ Q2 FY2024 | May 7, 2024 | -24.3% | $27.67 | $28.15 | +1.73% |
Q1 FY2026—
Report Date
Feb 17, 2026
EPS Beat/Miss
+731.5%
Price Before
$20.33
Price After
—
Q4 FY2025-5.92%
Report Date
Nov 12, 2025
EPS Beat/Miss
+2575.0%
Price Before
$27.35
Price After
$25.73
Q3 FY2025+2.64%
Report Date
Aug 4, 2025
EPS Beat/Miss
+5140.0%
Price Before
$34.46
Price After
$35.37
Q2 FY2025+5.34%
Report Date
May 13, 2025
EPS Beat/Miss
—
Price Before
$34.84
Price After
$36.70
Q1 FY2025+2.11%
Report Date
Feb 18, 2025
EPS Beat/Miss
+1211.5%
Price Before
$49.67
Price After
$50.72
Q4 FY2024-2.31%
Report Date
Nov 4, 2024
EPS Beat/Miss
+94.6%
Price Before
$30.68
Price After
$29.97
Q3 FY2024-9.55%
Report Date
Aug 5, 2024
EPS Beat/Miss
+14.3%
Price Before
$29.10
Price After
$26.32
Q2 FY2024+1.73%
Report Date
May 7, 2024
EPS Beat/Miss
-24.3%
Price Before
$27.67
Price After
$28.15
Avg Beat Reaction-2.61%
Avg Miss Reaction+1.73%
Beat Rate6 / 8 quarters
Largest Move-9.55% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SMLR ends December
Semler Scientific, Inc. (SMLR) most recently reported earnings on February 17, 2026 for Q1 FY2026, posting EPS of $3.41 — beating the analyst consensus of $-0.54 by +731.5%. SMLR has beaten EPS estimates for 6 consecutive quarters. The next SMLR earnings date is expected around September 1, 2026.
Each quarter, investors track SMLR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SMLR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SMLR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SMLR earnings · 5 questionsSemler Scientific, Inc.'s next earnings report is expected around September 1, 2026. SMLR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SMLR historically reports after market close (AMC).
SMLR earnings datewhen is SMLR earningsSMLR next earnings datewhen does SMLR report earningsSMLR earnings calendar
▸ Source: FMP · Semler Scientific, Inc. SEC filings · US GAAP · Semler Scientific, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026